Vigilant Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Vigilant Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7K	Hold	5,000	–	–	﹤0.01%	417
2023 Q1	$9K	Hold	5,000	–	–	﹤0.01%	393
2022 Q4	$16K	Hold	5,000	–	–	﹤0.01%	369
2022 Q3	$25K	Hold	5,000	–	–	﹤0.01%	362
2022 Q2	$21K	Hold	5,000	–	–	﹤0.01%	361
2022 Q1	$29K	Hold	5,000	–	–	﹤0.01%	344
2021 Q4	$38K	Hold	5,000	–	–	﹤0.01%	343
2021 Q3	$45K	Hold	5,000	–	–	﹤0.01%	279
2021 Q2	$60K	Hold	5,000	–	–	﹤0.01%	249
2021 Q1	$63K	Hold	5,000	–	–	0.01%	224
2020 Q4	$78K	Hold	5,000	–	–	0.01%	192
2020 Q3	$47K	Hold	5,000	–	–	0.01%	224
2020 Q2	$45K	Hold	5,000	–	–	0.01%	213
2020 Q1	$32K	Hold	5,000	–	–	﹤0.01%	230
2019 Q4	$42K	Hold	5,000	–	–	﹤0.01%	321
2019 Q3	$45K	Hold	5,000	–	–	0.01%	261
2019 Q2	$54K	Hold	5,000	–	–	0.01%	235
2019 Q1	$48K	Hold	5,000	–	–	0.01%	252
2018 Q4	$57K	Hold	5,000	–	–	0.01%	242
2018 Q3	$85K	Hold	5,000	–	–	0.01%	217
2018 Q2	$71K	Hold	5,000	–	–	0.01%	216
2018 Q1	$95K	Hold	5,000	–	–	0.01%	172
2017 Q4	$82K	Hold	5,000	–	–	0.01%	185
2017 Q3	$75K	Hold	5,000	–	–	0.01%	157
2017 Q2	$44K	Hold	5,000	–	–	0.01%	168
2017 Q1	$26K	Hold	5,000	–	–	﹤0.01%	201
2016 Q4	$15K	Hold	5,000	–	–	﹤0.01%	234
2016 Q3	$23K	Hold	5,000	–	–	﹤0.01%	223
2016 Q2	$29K	Hold	5,000	–	–	0.01%	197
2016 Q1	$30K	Hold	5,000	–	–	0.01%	179
2015 Q4	$46K	Hold	5,000	–	–	0.01%	166
2015 Q3	$28K	Hold	5,000	–	–	0.01%	187
2015 Q2	$55K	Hold	5,000	–	–	0.01%	175
2015 Q1	$78K	Hold	5,000	–	–	0.01%	150
2014 Q4	$76K	Hold	5,000	–	–	0.02%	160
2014 Q3	$54K	Hold	5,000	–	–	0.01%	150
2014 Q2	$76K	Buy	+5,000	New	+$71.9K	0.02%	123

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vigilant Capital Management's SGMO Position: Q2 2023 in Review

Vigilant Capital Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2023 at 5,000 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Vigilant Capital Management first reported a position in SGMO in Q2 2014 and has held it in 37 quarters since. The position peaked at $95K in Q1 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

Vigilant Capital Management held 5,000 shares of SANGAMO THERAPEUTICS INC worth $7K as of Q2 2023.
Vigilant Capital Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2023.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #417 holding.
Vigilant Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and has held it in 37 quarters since.
Vigilant Capital Management's SANGAMO THERAPEUTICS INC position peaked at $95K in Q1 2018.
152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.